In lipopolysaccharide (LPS)-induced AKI mice, fisetin alleviates renal inflammation through the modulation of the NF-κB p65 and MAPK signaling pathways (Ren et al., 2020; Zheng et al., 2024). Here, NFKB1 is linked to acute kidney injury.